This series of annual volumes on biomedical policy identifies cutting-edge issues that arise from a rapidly growing array of new technologies. Volume II focuses on two substantive areas beset by novel power conflicts: decisions involving end-of-life technologies - physicians, patients, and public officials locked in new battles over whether and when life-extending technologies should be begun or ended, and rules governing medical experimentation - researchers, government officials, and patients vying to determine who will receive experimental medical treatment and what procedures should be instituted to protect the recipients.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : Theoria Books, Andover, MA, Etats-Unis
Hardcover. Etat : As New. Etat de la jaquette : As New. 1st Edition. 273 pp., xi. '1' in number line. Contents divided into 17 Essays in 2 Parts: Part I DEBATES OVER AUTHORITY IN MEDICAL DECISION-MAKING Andrea L. Bonnicksen, "Introduction"; (1) William J. Winslade, "End-of-Life Medicine, Law, and Ethics: A Twilight Zone"; (2) John J. Paris and Frank Reardon, "Physician Refusal of Requests for Futile or Ineffective Interventions"; (3) Tom Tomlinson, "Refusing Demands for Attempted Resuscitation: Ethics and Hospital Policy"; (4) Robert Baker and Martin Strosberg, "The Bioethical Revolution of 1988: The Future of the Futility Controversy"; (5) Marion Danis and Larry Churchill, "Evolving Trends for Advance Directives"; (6) Timothy E. Quill, "A Case of Individualized Decision Making"; (7) Albert R. Jonsen, "Reflection on Washington State's Initiative 119"; (8) Robert W. Wood and Ralph Mero, "Washington State's ' Death with Dignity ' Initiative"; (9) Richard M. Zaner and Mark D. Fox, "Selective Termination and Moral Risk: Choices and Responsibility"; (10) Eugene Pergament. "In Utero Treatment: Fetal Surgery"; Part II NEW CHALLENGES IN MEDICAL EXPERIMENTATION Robert H. Blank, "Introduction'; (11) Charles R. McCarthy, "Overview: Challenges for the 1990s"; (12) Carol Levine, "Women as Research Subjects: New Priorities, New Questions"; (13) Joan Porter, Marta Glass, and Wayne Koff, "International AIDS Vaccine Trials"; (14) John C. Fletcher, "Human Fetal and Embryo Research: Lysenkoism in Reverse--How and Why?"; (15) Mary B. Mahowald, "Brain Development, Personality, and Neurografts"; (16) Deborah Mathieu, "Ending the Experiment: Dilemmas of the Experimental/Therapeutic Distinction"; (17) Arnold E. Relman, "Economic Incentives in Clinical Investigation"; "About the Contributors", pp. 269-273. Blue cloth with brilliant gilt lettering on spne; Medium gray endpapers. Glossy dustwrapper not price-clipped (NO price) with medium gray vertical side borders for vertical light gray wide strip down middle front cover, with larger and smaller yellow Title and Editor Names boxes (for dark blue lettering) across top and bottom front cover, respectively. Very faint stain at foot of fore-edge (trapezoidal, 3/8" x 5/8", light Tan [vs. white remainder]; NO warping, NO odor, NO bleeding onto truly trivial); Cosmetic: very small bump-wrinkle to dw only at top spine and small dimple at gutter just below midpoint on left front cover, else unqualifiedly As New: Review Copy with Review slip laid in (Orig. Price in 1993, $45.00): Tight binding (NO cracks); Sharp corners (NO bumps or curls);NO rubbing wear; NO previous owner names. Clean text. UNREAD. Essentially: Flawless. N° de réf. du vendeur 002959
Quantité disponible : 1 disponible(s)